Journal Information

Statistics

Follow this link to access the full text of the article

Letter - Clinical
Hybrid tumor ‘spiradenocylindroma’ with unusual dermoscopic features
Ecem Bostana,
Corresponding author
bostanecem@gmail.com

Corresponding author.
, Etkin Boynuyogunb, Ozay Gokozc, Ibrahim Vargelb
a Cihanbeyli Public Hospital, Konya, Turkey
b Department of Plastic and Reconstructive Surgery, Hacettepe University, Faculty of Medicine, Ankara, Turkey
c Department of Pathology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
Read
5361
Times
was read the article
2090
Total PDF
3271
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 31 18 49
2025 5 167 57 224
2025 4 159 47 206
2025 3 148 50 198
2025 2 164 87 251
2025 1 115 84 199
2024 12 115 96 211
2024 11 154 66 220
2024 10 139 95 234
2024 9 196 126 322
2024 8 192 128 320
2024 7 135 108 243
2024 6 110 70 180
2024 5 96 62 158
2024 4 109 105 214
2024 3 97 83 180
2024 2 86 88 174
2024 1 62 51 113
2023 12 72 63 135
2023 11 89 95 184
2023 10 65 84 149
2023 9 79 83 162
2023 8 52 36 88
2023 7 107 43 150
2023 6 172 61 233
2023 5 142 58 200
2023 4 93 16 109
2023 3 42 49 91
2023 2 40 38 78
2023 1 43 43 86
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.